| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |